Abbott Laboratories (ABT)
118.60
+5.23
(+4.61%)
USD |
NYSE |
Nov 01, 16:00
119.14
+0.54
(+0.46%)
After-Hours: 20:00
Abbott Laboratories Market Cap: 205.71B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 205.71B |
| October 31, 2024 | 196.64B |
| October 30, 2024 | 198.51B |
| October 29, 2024 | 196.69B |
| October 28, 2024 | 197.85B |
| October 25, 2024 | 198.11B |
| October 24, 2024 | 202.13B |
| October 23, 2024 | 202.95B |
| October 22, 2024 | 201.41B |
| October 21, 2024 | 202.91B |
| October 18, 2024 | 207.08B |
| October 17, 2024 | 204.48B |
| October 16, 2024 | 204.35B |
| October 15, 2024 | 201.28B |
| October 14, 2024 | 203.36B |
| October 11, 2024 | 201.41B |
| October 10, 2024 | 200.54B |
| October 09, 2024 | 201.11B |
| October 08, 2024 | 198.82B |
| October 07, 2024 | 196.62B |
| October 04, 2024 | 195.37B |
| October 03, 2024 | 194.66B |
| October 02, 2024 | 197.10B |
| October 01, 2024 | 196.96B |
| September 30, 2024 | 197.75B |
| Date | Value |
|---|---|
| September 27, 2024 | 195.62B |
| September 26, 2024 | 196.14B |
| September 25, 2024 | 195.93B |
| September 24, 2024 | 197.20B |
| September 23, 2024 | 199.76B |
| September 20, 2024 | 197.83B |
| September 19, 2024 | 198.61B |
| September 18, 2024 | 199.88B |
| September 17, 2024 | 205.53B |
| September 16, 2024 | 204.66B |
| September 13, 2024 | 202.52B |
| September 12, 2024 | 203.27B |
| September 11, 2024 | 202.87B |
| September 10, 2024 | 203.76B |
| September 09, 2024 | 202.58B |
| September 06, 2024 | 198.10B |
| September 05, 2024 | 196.78B |
| September 04, 2024 | 199.04B |
| September 03, 2024 | 199.50B |
| August 30, 2024 | 197.08B |
| August 29, 2024 | 196.19B |
| August 28, 2024 | 196.43B |
| August 27, 2024 | 196.78B |
| August 26, 2024 | 196.09B |
| August 23, 2024 | 196.07B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
110.78B
Minimum
Mar 23 2020
250.14B
Maximum
Dec 27 2021
189.64B
Average
190.46B
Median
Market Cap Benchmarks
| Boston Scientific Corp | 123.14B |
| Becton Dickinson & Co | 67.99B |
| ResMed Inc | 35.86B |
| Integra Lifesciences Holdings Corp | 1.496B |
| QuidelOrtho Corp | 2.629B |
Market Cap Related Metrics
| PE Ratio | 36.05 |
| PS Ratio | 5.031 |
| PEG Ratio | 3.028 |
| Price to Book Value | 5.169 |
| Price to Free Cash Flow | 31.97 |
| Price | 118.60 |
| Earnings Yield | 2.77% |
| PEGY Ratio | 2.620 |
| Operating PE Ratio | 30.98 |
| Normalized PE Ratio | 36.00 |